Protandim on PubMed
The are 8 published studies featuring Protandim on Pubmed.gov. This is a remarkable achievement. Protandim is the only supplement clinically proven to reduce oxidative stress by an average 40%, slowing down the cell aging process to the level of a 20 year-old.* While conventional or direct antioxidants can neutralize only one free radical molecule, Protandim triggers the creation of enzymes that can each eliminate over a million free radical molecules per second without being used up. Click on the button below to view the studies.
The role of manganese superoxide dismutase in skin cancer.
Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway.
The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.
The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis.
Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.
Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim.
The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy.